Cargando…
Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
OBJECTIVE: To recognize risk factors and build up and validate a simple risk model predicting 8‐year cancer events after nonalcoholic fatty liver disease (NAFLD). METHODS: This was a retrospective cohort study. Patients with NAFLD (n = 5561) were randomly divided into groups: training (n = 1254), te...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997093/ https://www.ncbi.nlm.nih.gov/pubmed/31860170 http://dx.doi.org/10.1002/cam4.2777 |
_version_ | 1783493620882472960 |
---|---|
author | Wei, Zihan Ren, Zhigang Hu, Shuang Gao, Yan Sun, Ranran Lv, Shuai Yang, Guojie Yu, Zujiang Kan, Quancheng |
author_facet | Wei, Zihan Ren, Zhigang Hu, Shuang Gao, Yan Sun, Ranran Lv, Shuai Yang, Guojie Yu, Zujiang Kan, Quancheng |
author_sort | Wei, Zihan |
collection | PubMed |
description | OBJECTIVE: To recognize risk factors and build up and validate a simple risk model predicting 8‐year cancer events after nonalcoholic fatty liver disease (NAFLD). METHODS: This was a retrospective cohort study. Patients with NAFLD (n = 5561) were randomly divided into groups: training (n = 1254), test (n = 627), evaluation (n = 627), and validation (n = 3053). Risk factors were recognized by statistical method named as a Cox model with Markov chain Monte Carlo (MCMC) simulation. This prediction score was established based on the training group and was further validated based on the testing and evaluation group from January 1, 2007 to December 31, 2009 and another 3053 independent cases from January 1, 2010 to February 13, 2014. RESULTS: The main outcomes were NAFLD‐related cancer events, including those of the liver, breast, esophagus, stomach, pancreas, prostate and colon, within 8 years after hospitalization for NAFLD diagnosis. Seven risk factors (age (every 5 years),LDL, smoking, BMI, diabetes, OSAS, and aspartate aminotransferase (every 5 units)) were identified as independent indicators of cancer events. This risk model contained a predictive range of 0.4%‐37.7%, 0.3%‐39.6%, and 0.4%‐39.3% in the training, test, evaluation group, respectively, with a range 0.4%‐30.4% for validation groups. In the training group, 12.6%, 76.9%, and 10.5% of patients, which corresponded to the low ‐, moderate ‐, and high‐risk groups, had probabilities of, <0.01, <0.1, and 0.23 for 8‐year events. CONCLUSIONS: Seven risk factors were recognized and a simple risk model were developed and validated to predict the risk of cancer events after NAFLD based on 8 years. This simple risk score system may recognize high‐risk patients and reduce cancer incidence. |
format | Online Article Text |
id | pubmed-6997093 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69970932020-02-05 Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease Wei, Zihan Ren, Zhigang Hu, Shuang Gao, Yan Sun, Ranran Lv, Shuai Yang, Guojie Yu, Zujiang Kan, Quancheng Cancer Med Cancer Prevention OBJECTIVE: To recognize risk factors and build up and validate a simple risk model predicting 8‐year cancer events after nonalcoholic fatty liver disease (NAFLD). METHODS: This was a retrospective cohort study. Patients with NAFLD (n = 5561) were randomly divided into groups: training (n = 1254), test (n = 627), evaluation (n = 627), and validation (n = 3053). Risk factors were recognized by statistical method named as a Cox model with Markov chain Monte Carlo (MCMC) simulation. This prediction score was established based on the training group and was further validated based on the testing and evaluation group from January 1, 2007 to December 31, 2009 and another 3053 independent cases from January 1, 2010 to February 13, 2014. RESULTS: The main outcomes were NAFLD‐related cancer events, including those of the liver, breast, esophagus, stomach, pancreas, prostate and colon, within 8 years after hospitalization for NAFLD diagnosis. Seven risk factors (age (every 5 years),LDL, smoking, BMI, diabetes, OSAS, and aspartate aminotransferase (every 5 units)) were identified as independent indicators of cancer events. This risk model contained a predictive range of 0.4%‐37.7%, 0.3%‐39.6%, and 0.4%‐39.3% in the training, test, evaluation group, respectively, with a range 0.4%‐30.4% for validation groups. In the training group, 12.6%, 76.9%, and 10.5% of patients, which corresponded to the low ‐, moderate ‐, and high‐risk groups, had probabilities of, <0.01, <0.1, and 0.23 for 8‐year events. CONCLUSIONS: Seven risk factors were recognized and a simple risk model were developed and validated to predict the risk of cancer events after NAFLD based on 8 years. This simple risk score system may recognize high‐risk patients and reduce cancer incidence. John Wiley and Sons Inc. 2019-12-20 /pmc/articles/PMC6997093/ /pubmed/31860170 http://dx.doi.org/10.1002/cam4.2777 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cancer Prevention Wei, Zihan Ren, Zhigang Hu, Shuang Gao, Yan Sun, Ranran Lv, Shuai Yang, Guojie Yu, Zujiang Kan, Quancheng Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease |
title | Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease |
title_full | Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease |
title_fullStr | Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease |
title_full_unstemmed | Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease |
title_short | Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease |
title_sort | development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease |
topic | Cancer Prevention |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997093/ https://www.ncbi.nlm.nih.gov/pubmed/31860170 http://dx.doi.org/10.1002/cam4.2777 |
work_keys_str_mv | AT weizihan developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease AT renzhigang developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease AT hushuang developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease AT gaoyan developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease AT sunranran developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease AT lvshuai developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease AT yangguojie developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease AT yuzujiang developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease AT kanquancheng developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease |